Comment on: Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 3, 2009, Pages 627-628

  Tam, Vincent H ^a   Hou, Jingguo ^a   Kwa, Andrea L ^b   Prince, Randall A ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Assays; HPLC; Polymyxin B

Indexed keywords

ANTIINFECTIVE AGENT; POLYMYXIN B;

ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; DRUG ABSORPTION; DRUG ANALYSIS; DRUG DETERMINATION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG QUALITY; GRAM NEGATIVE BACTERIUM; HUMAN; MULTIDRUG RESISTANCE; NOTE; PHARMACODYNAMICS; PREVALENCE; PROCESS DEVELOPMENT; QUALITY CONTROL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

CHROMATOGRAPHY, LIQUID; HUMANS; PLASMA; POLYMYXIN B;

EID: 60649104004     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn483     Document Type: Note

References (4)

1. Cao G, Ali FE, Chiu F et al. Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma. J Antimicrob Chemother 2008; 62 1009-14.
2. Kwa AL, Lim TP, Low JG et al. Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections. Diagn Microbiol Infect Dis 2008; 60: 163-7.
3. Tam VH, Schilling AN, Vo G et al. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005; 49: 3624-30.
4. Orwa JA, Van Gerven A, Roets E et al. Liquid chromatography of polymyxin B sulphate. J Chromatogr A 2000; 870: 237-43.